side effects of glp-1 drugs GI Adverse Glucagon-Like Peptide-1 Receptor Agonists GLP-1 drugs are changing the
Description
The Cochrane Risk of Bias tool was used to assess the quality of studies
Initial combination therapy or maintenance of combination therapy may not be appropriate for all patients
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
(13) Additionally, GLP-1 signaling may help suppress pro-inflammatory pathways, reducing the chronic low-grade inflammation associated with both obesity and bone loss
However, so far most of the research work done has been on animals [36]
A.WeirV
